Search Results for: Laboratory

May 15, 2025

Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients with severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023.

Publication date: May 12, 2025 Understanding the epidemiology of SARS-CoV-2 infection in settings with limited data, especially given the dynamic nature of the virus and the reported epidemiological heterogeneity across ... Read more

May 10, 2025May 10, 2025

Within-laboratory SARS-CoV-2 real time PCR testing operations in Nepal: a simulation-based analysis.

Coronavirus Literature

Publication date: May 01, 2025 COVID-19 has challenged entire health systems, including laboratories. To address the increasing demand for tests to inform the epidemiology of the disease and for case ... Read more

April 28, 2025

The Clinical and Laboratory Landscape of COVID-19 During the Initial Period of the Pandemic and at the Beginning of the Omicron Era.

Coronavirus Literature

Publication date: Mar 27, 2025 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underwent significant mutations, resulting in the Omicron variant. In this study, we analyzed blood samples from 98 patients ... Read more

April 26, 2025April 26, 2025

Assessing the evidence for antibiotic management of laboratory-confirmed Streptococcus A skin infections to prevent acute rheumatic fever and rheumatic heart disease: a systematic review.

Coronavirus Literature

Publication date: Jun 01, 2025 Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are potential sequelae of untreated group A streptococcal (Strep A) infections. Guidelines focus on treating Strep ... Read more

April 25, 2025April 25, 2025

Parent-reported experiences of in-laboratory polysomnography in children with neurodevelopmental disorders: A cross-sectional multi-centre study.

Autism Literature

Publication date: Apr 24, 2025 In-laboratory polysomnography (PSG) is the gold standard test for diagnosing certain paediatric sleep conditions. Children with neurodevelopmental disorders (NDD) often have difficulty tolerating PSG, but ... Read more

April 23, 2025April 23, 2025

Analyzing Functionalized Carbon Quantum Dots in Electrode Engineering for the Precise Electrochemical Detection of a Neurotransmitter: Achieving Laboratory Accuracy with Portable Sensors.

Parkinson's Disease Literature

Publication date: Apr 22, 2025 Point-of-care testing (POCT) devices are revolutionizing health monitoring by enabling rapid and accessible testing outside conventional laboratory environments. However, achieving laboratory-level accuracy in these portable ... Read more

April 20, 2025April 20, 2025

Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network.

Coronavirus Literature

Publication date: Jan 31, 2025 The CEPI-Centralized Laboratory Network (CLN) has significantly contributed to the development of several approved SARS-CoV-2 vaccines by conducting over 70,000 clinical samples for testing from ... Read more

May 21, 2025

Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly Populations: a Multicenter Randomized Controlled Trial

Parkinson's Disease News

Publication date: May 16, 2025 The goal of this randomized controlled trial is to evaluate the effectiveness of wearable devices (Huawei smartwatches) in aiding the detection, and screening of major ... Read more

May 21, 2025May 21, 2025

Co-Infection of Mucormycosis and COVID-19: A Retrospective Cross-Sectional Study of Patients Admitted to Imam Khomeini Hospital in Ahvaz, Iran.

Coronavirus Literature

Publication date: May 01, 2025 During the COVID-19 pandemic, the emergence of mucormycosis, a rare but often fatal fungal infection, gained significant attention due to its increased prevalence among immunocompromised ... Read more

May 21, 2025May 21, 2025

Long-term safety and tolerability of zavegepant 10-mg nasal spray with concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open-label study.

Coronavirus Literature

Publication date: May 20, 2025 To evaluate the safety and tolerability of zavegepant (ZAV) when used as needed for acute treatment of migraine in patients taking concomitant preventive migraine medications ... Read more